DRKS00003204
Recruiting
N/A
on-interventional study for the analysis of efficacy and safety of EstraCept(R) 280 mg (Estramustin phosphate) at patients with castration resistant prostate cancer in three therapy situations - EMPire
PharmaCept GmbH0 sites300 target enrollmentAugust 3, 2011
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- PharmaCept GmbH
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Castration resistant prostate cancer
- •Advanced status
- •Hormone refractory
- •Signed patient informed consent
Exclusion Criteria
- •As described in the product information
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
on-interventional study to analyse the efectiveness and tolerance of chemotherapy with Docetaxel NC(R) or Doce NC (R) during the treatment of breast cancer and prostate cancer as an application for the daily routineC50C61Malignant neoplasm of breastMalignant neoplasm of prostateDRKS00004502eocorp GmbH450
Active, Not Recruiting
N/A
Study to investigate the effectiveness of emicizumab under real-world conditions in paediatric, adolescent, adult and elderly participants with haemophilia A with and without Factor VIII (FVIII) inhibitorsISRCTN58752772Roche (Germany)168
Not Yet Recruiting
N/A
A study to assess the effectiveness of â??Nurse Led Interventionâ?? on treatment adherence and quality of life among patients having Glaucoma.Health Condition 1: H401- Open-angle glaucomaHealth Condition 2: H402- Primary angle-closure glaucomaCTRI/2021/08/035706INE
Not Yet Recruiting
N/A
A study to assess the effectiveness of Nurse led counselling programme on the adherence of eye patch application among patient of AmblyopiaHealth Condition 1: H518- Other specified disorders of binocular movementCTRI/2019/06/019641PGIMER Chandigarh
Not Yet Recruiting
Phase 3
A study to assess the action of homeopathic medicines in hypertensioHealth Condition 1: I10- Essential (primary) hypertensionCTRI/2023/07/055348Dr M P K Homoeopathic Medical College Hospital and Research Centre